Hong Kong, Macao Block Use Of Allopurinol After Five Deaths
This article was originally published in PharmAsia News
Macao and Hong Kong authorities have taken action against the allopurinol gout drug made by Europharm Laboratories following five death reports. Macao ordered the drug recalled and imports blocked while Hong Kong SAR's Health Department urged a halt to use of the drug. Batches made by the Hong Kong-based pharma were discovered to have been tainted with fungal contamination. Health authorities in Hong Kong, where about 40,000 patients have received the drug, said they found a bacteria mucormycosis level in some batches 100 times more than the standard amount. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.